Tekmira soars on clinical hold conversion for TKM-Ebola

Tekmira Pharmaceuticals Corp. (TSX:TKM; NASDAQ:TKMR) jumped $6.43 (45%) to $20.70 on NASDAQ and C$7.39 (47%) to C$23 in Toronto on Friday after announcing late Thursday that FDA converted to a partial...